Leif Göran Kvist
Keine laufenden Positionen mehr
Karriereverlauf von Leif Göran Kvist
Ehemalige bekannte Positionen von Leif Göran Kvist
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Vorsitzender | - | - |
Gründer | - | - | |
QP Support AB | Vorsitzender | - | - |
Gründer | - | - | |
ACUCORT AB | Direktor/Vorstandsmitglied | 11.07.2013 | - |
TQ Kvalitetskonsult AB
TQ Kvalitetskonsult AB Miscellaneous Commercial ServicesCommercial Services TQ Kvalitetskonsult AB provides science and technology research and development services. The private company is based in Morarp, Sweden. | Vorstandsvorsitzender | - | - |
Vorsitzender | - | - | |
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Vorsitzender | 01.01.2003 | - |
Gründer | 01.01.2003 | - |
Ausbildung von Leif Göran Kvist
University of Uppsala | Undergraduate Degree |
Statistik
International
Schweden | 7 |
Operativ
Chairman | 4 |
Founder | 3 |
Director/Board Member | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ACUCORT AB | Health Technology |
Private Unternehmen | 4 |
---|---|
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Health Technology |
TQ Kvalitetskonsult AB
TQ Kvalitetskonsult AB Miscellaneous Commercial ServicesCommercial Services TQ Kvalitetskonsult AB provides science and technology research and development services. The private company is based in Morarp, Sweden. | Commercial Services |
QP Support AB | |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Health Technology |
- Börse
- Insiders
- Leif Göran Kvist
- Erfahrung